These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23425969)

  • 1. Synthesis, in vitro antiplatelet activity and molecular modelling studies of 10-substituted 2-(1-piperazinyl)pyrimido[1,2-a]benzimidazol-4(10H)-ones.
    Di Braccio M; Grossi G; Signorello MG; Leoncini G; Cichero E; Fossa P; Alfei S; Damonte G
    Eur J Med Chem; 2013 Apr; 62():564-78. PubMed ID: 23425969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity.
    Martin MW; Newcomb J; Nunes JJ; Boucher C; Chai L; Epstein LF; Faust T; Flores S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Kim JL; Middleton S; Morgenstern K; Oliveira-dos-Santos A; Patel VF; Powers D; Rose P; Tudor Y; Turci SM; Welcher AA; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Ermann M; Johnston D; Saluste CG
    J Med Chem; 2008 Mar; 51(6):1637-48. PubMed ID: 18278858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2-fused pyrimidines. VI. Substituted 2-amino-4H-pyrido[1,2-a]pyrimidin-4-ones with antiplatelet activity.
    Roma G; Di Braccio M; Leoncini G; Aprile B
    Farmaco; 1993 Sep; 48(9):1225-38. PubMed ID: 8259980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antiplatelet activity and comparative molecular field analysis of substituted 2-amino-4H-pyrido[1,2-a]pyrimidin-4-ones, their congeners and isosteric analogues.
    Roma G; Cinone N; Di Braccio M; Grossi G; Leoncini G; Signorello MG; Carotti A
    Bioorg Med Chem; 2000 Apr; 8(4):751-68. PubMed ID: 10819164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pyrimido[5,4-c]cinnolines with antiplatelet activities.
    Rehse K; Gonska H
    Arch Pharm (Weinheim); 2005 Dec; 338(12):590-7. PubMed ID: 16281308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis.
    Roma G; Braccio MD; Carrieri A; Grossi G; Leoncini G; Grazia Signorello M; Carotti A
    Bioorg Med Chem; 2003 Jan; 11(1):123-38. PubMed ID: 12467715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic guanidines: synthesis and antiplatelet activity of 4,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyrazolo[3,4-d]pyrimidin-7-ones and 1,4,6,7,8,9-hexahydropyrazolo [3',4':4,5]pyrimido[2,1-c] [1,2,4]triazin-7-ones.
    Ferroni R; Simoni D; Orlandini P; Bardi A; Franze GP; Guarneri M
    Arzneimittelforschung; 1990 Dec; 40(12):1328-31. PubMed ID: 2095128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and exploration of QSAR model of 2-methyl-3-[2-(2-methylprop-1-en-1-yl)-1H-benzimidazol-1-yl]pyrimido[1,2-a]benzimidazol-4(3H)-one as potential antibacterial agents.
    Sharma P; Kumar A; Sharma M; Singh J; Bandyopadhyay P; Sathe M; Kaushik MP
    J Enzyme Inhib Med Chem; 2012 Apr; 27(2):294-301. PubMed ID: 21699375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site.
    Roma G; Di Braccio M; Grossi G; Piras D; Leoncini G; Bruzzese D; Signorello MG; Fossa P; Mosti L
    J Med Chem; 2007 Jun; 50(12):2886-95. PubMed ID: 17500510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyran derivatives XIX. (Dialkylamino) substituted 1-benzopyranones and naphthopyranones with platelet antiaggregating activity.
    Di Braccio M; Roma G; Leoncini G; Poggi M
    Farmaco; 1995 Oct; 50(10):703-11. PubMed ID: 8590578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7,8-di and 8-substituted)-1,3-benzoxazines.
    Ihmaid SK; Al-Rawi JM; Bradley CJ; Angove MJ; Robertson MN
    Eur J Med Chem; 2012 Nov; 57():85-101. PubMed ID: 23059543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitors.
    Hubschwerlen C; Pflieger P; Specklin JL; Gubernator K; Gmünder H; Angehrn P; Kompis I
    J Med Chem; 1992 Apr; 35(8):1385-92. PubMed ID: 1315393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
    Wang WY; Hsieh PW; Wu YC; Wu CC
    Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of some N-substituted derivatives of 2-methyl-10H-pyrimido[1,2-a]benzimidazol-4-one and 2-phenyl-10H-pyrimido[1,2-a]benzimidazol-4-one with potential pharmacological activity.
    Zawadowski T; Klimaszewska M
    Acta Pol Pharm; 1994; 51(4-5):351-3. PubMed ID: 7701949
    [No Abstract]   [Full Text] [Related]  

  • 17. New platelet aggregation inhibitors based on pyridazinone moiety.
    Costas T; Costas-Lago MC; Vila N; Besada P; Cano E; Terán C
    Eur J Med Chem; 2015 Apr; 94():113-22. PubMed ID: 25757094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolizidinyl-benzimidazoles as platelet-antiaggregating agents.
    Vazzana I; Terranova E; Tasso B; Tonelli M; Piana A; Gastaldi S; Sparatore F
    Chem Biodivers; 2008 May; 5(5):714-28. PubMed ID: 18493958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE SEARCH OF COMPOUNDS WITH ANTIAGGREGATION ACTIVITY AMONG S-ESTERS OF THIOSULFONIC ACIDS.
    Halenova TI; Nikolaeva IV; Nakonechna AV; Bolibrukh KB; Monka NY; Lubenets VI; Savchuk OM; Novikov VP; Ostapchenko LI
    Ukr Biochem J; 2015; 87(5):83-92. PubMed ID: 26717599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,5-Benzodiazepines. X. Dialkylamino substituted 1,5-benzodiazepine and [1,2,4]triazolo [4,3-a][1,5] benzodiazepine derivatives with inhibitory activity on PAF-induced platelet aggregation.
    Di Braccio M; Roma G; Grossi GC; Leoncini G; Maresca M
    Farmaco; 1992 Jan; 47(1):77-90. PubMed ID: 1616579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.